COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, cardiovascular and orthopedic areas, announced today that C. Randal Mills, Ph.D., President and Chief Executive Officer, is scheduled to present at the 2010 UBS Global Life Sciences Conference on Monday, September 20, 2010 at 4:30 p.m. EDT.
